Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,025 | 2 | 62.5% |
| Food and Beverage | $614.37 | 9 | 37.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,557 | 8 | $0 (2024) |
| Horizon Therapeutics plc | $49.73 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $31.94 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $259.40 | 3 | ABBVIE INC. ($259.40) |
| 2023 | $1,298 | 5 | ABBVIE INC. ($1,298) |
| 2022 | $81.67 | 3 | Horizon Therapeutics plc ($49.73) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/26/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $119.72 | General |
| Category: EYE CARE | ||||||
| 01/26/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $118.10 | General |
| Category: EYE CARE | ||||||
| 01/26/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: EYE CARE | ||||||
| 11/30/2023 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Travel and Lodging | In-kind items and services | $608.36 | General |
| Category: EYE CARE | ||||||
| 11/30/2023 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Travel and Lodging | In-kind items and services | $416.35 | General |
| Category: EYE CARE | ||||||
| 11/14/2023 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $108.22 | General |
| Category: EYE CARE | ||||||
| 03/03/2023 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $82.54 | General |
| Category: EYE CARE | ||||||
| 03/02/2023 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $82.54 | General |
| Category: EYE CARE | ||||||
| 06/06/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/25/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/14/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $49.73 | General |
| Category: TEPEZZA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 343 | 363 | $67,585 | $11,793 |
| 2022 | 7 | 220 | 232 | $34,699 | $7,810 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Facility | 2023 | 66 | 73 | $18,522 | $3,048 | 16.5% |
| 92004 | New patient complete exam of visual system | Facility | 2023 | 47 | 47 | $15,016 | $2,321 | 15.5% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 23 | 23 | $8,740 | $1,584 | 18.1% |
| 92012 | Established patient problem focused exam of visual system | Facility | 2023 | 26 | 33 | $6,132 | $1,145 | 18.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 17 | 21 | $4,620 | $840.21 | 18.2% |
| 92083 | Exam of visual field with extended testing | Facility | 2023 | 54 | 54 | $3,242 | $834.67 | 25.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 11 | 11 | $3,498 | $663.74 | 19.0% |
| 92133 | Imaging of optic nerve | Facility | 2023 | 47 | 48 | $4,176 | $542.60 | 13.0% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 12 | 13 | $1,040 | $312.13 | 30.0% |
| 92136 | Measurement of corneal curvature and depth of eye | Facility | 2023 | 15 | 15 | $1,200 | $307.27 | 25.6% |
| 92020 | Exam of the internal drainage system of eye | Facility | 2023 | 11 | 11 | $1,049 | $136.92 | 13.1% |
| 76514 | Ultrasound scan of cornea to determine thickness | Facility | 2023 | 14 | 14 | $350.00 | $57.56 | 16.4% |
| 92004 | New patient complete exam of visual system | Facility | 2022 | 42 | 42 | $12,642 | $2,899 | 22.9% |
| 92014 | Established patient complete exam of visual system | Facility | 2022 | 36 | 40 | $10,000 | $2,208 | 22.1% |
| 92083 | Exam of visual field with extended testing | Facility | 2022 | 44 | 45 | $3,155 | $875.16 | 27.7% |
| 92012 | Established patient problem focused exam of visual system | Facility | 2022 | 15 | 20 | $3,460 | $748.40 | 21.6% |
| 92133 | Imaging of optic nerve | Facility | 2022 | 39 | 41 | $2,869 | $641.20 | 22.3% |
| 92020 | Exam of the internal drainage system of eye | Facility | 2022 | 20 | 20 | $2,020 | $299.80 | 14.8% |
| 76514 | Ultrasound scan of cornea to determine thickness | Facility | 2022 | 24 | 24 | $553.00 | $138.24 | 25.0% |
About Dr. Mohammad Pakravan, MD
Dr. Mohammad Pakravan, MD is a Glaucoma Specialist healthcare provider based in League City, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2021. The National Provider Identifier (NPI) number assigned to this provider is 1609459239.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammad Pakravan, MD has received a total of $1,639 in payments from pharmaceutical and medical device companies, with $259.40 received in 2024. These payments were reported across 11 transactions from 3 companies. The most common payment nature is "Travel and Lodging" ($1,025).
As a Medicare-enrolled provider, Pakravan has provided services to 563 Medicare beneficiaries, totaling 595 services with total Medicare billing of $19,602. Data is available for 2 years (2022–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Glaucoma Specialist
- Other Specialties Ophthalmology
- Location League City, TX
- Active Since 05/02/2021
- Last Updated 10/07/2025
- Taxonomy Code 207WX0009X
- Entity Type Individual
- NPI Number 1609459239
Products in Payments
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $1,475
- DURYSTA (Drug) $82.54
- TEPEZZA (Drug) $49.73
- XIIDRA (Drug) $31.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.